Close this search box.

Mesothelioma Clinical Trials

Mesothelioma is a rare and devastating form of cancer. It often has a poor prognosis despite an aggressive treatment plan. Clinical trials help researchers learn more about the cancer and how to treat it effectively. It involves testing research methods on real-world mesothelioma patients, which may include experimental drugs and treatment protocols.

Patients with pleural mesothelioma, the most common form of the disease, have a median life expectancy of just 15 to 22 months with standard treatment. This dire prognosis often motivates mesothelioma patients to look for alternative treatment options. Clinical trials provide mesothelioma patients with hope, especially for patients whose specific cases have left them with limited treatment options.

What are clinical trials?

Clinical trials are FDA-regulated research studies that test experimental new drugs and treatment protocols on human volunteers. They are funded by both public agencies and private institutions, such as universities. The leader of a clinical study, often a doctor, is known as the principal investigator, and the entity funding each study is the sponsor. 

lab worker looking in microscope

How do clinical trials work?

Clinical trials are used to increase medical knowledge and test treatment in response to research findings. The two primary types of clinical trials are observational and interventional. In observational studies, investigators assess health outcomes that stem from interventions, but participants are not assigned interventions via the study.

Interventional clinical studies test treatment protocols through controlled studies.